Artigos (16) Publicacións nas que participase algún/ha investigador/a Ver datos de investigación referenciados.

no ano 2009 Eliminar o filtro
filter_list Tipo (agr.) Artigos Desde o ano 2009 Ata o ano 2009 Endocrinology

2009

  1. Adipokines in the skeleton: Influence on cartilage function and joint degenerative diseases

    Journal of Molecular Endocrinology, Vol. 43, Núm. 1, pp. 11-18

  2. Alterations in hypothalamic kiSS-1 system in experimental diabetes: Early changes and functional consequences

    Endocrinology, Vol. 150, Núm. 2, pp. 784-794

  3. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion

    Endocrinology, Vol. 150, Núm. 10, pp. 4562-4574

  4. Guía clínica para el diagnóstico y el tratamiento de la disfunción tiroidea subclínica en la gestación

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 56, Núm. 2, pp. 85-91

  5. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.

    Thyroid : official journal of the American Thyroid Association, Vol. 19, Núm. 6, pp. 645-649

  6. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats

    Journal of Clinical Endocrinology and Metabolism, Vol. 94, Núm. 1, pp. 277-284

  7. Inflammatory and granulomatous expansive lesions of the pituitary

    Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 23, Núm. 5, pp. 639-650

  8. La cistatina C aporta más información que otros parámetros de función renal en la estratificación del riesgo de los pacientes con síndrome coronario agudo

    Revista Espanola de Cardiologia, Vol. 62, Núm. 5, pp. 510-519

  9. Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

    European Journal of Endocrinology, Vol. 161, Núm. 4, pp. 533-540

  10. Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: Its efficacy in relation to gender and previous radio therapy

    European Journal of Endocrinology, Vol. 160, Núm. 4, pp. 535-542

  11. Obestatin stimulates Akt signalling in gastric cancer cells through β-arrestin-mediated epidermal growth factor receptor transactivation

    Endocrine-Related Cancer, Vol. 16, Núm. 2, pp. 599-611

  12. Pegvisomant-induced cholestatic hepatitis with jaundice in a patient with Gilbert's syndrome

    European Journal of Endocrinology, Vol. 160, Núm. 5, pp. 869-872

  13. Resistin regulates pituitary somatotrope cell function through the activation of multiple signaling pathways

    Endocrinology, Vol. 150, Núm. 10, pp. 4643-4652

  14. Role of obestatin on growth hormone secretion: An in vitro approach

    Biochemical and Biophysical Research Communications, Vol. 390, Núm. 4, pp. 1377-1381

  15. The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system

    Endocrinology, Vol. 150, Núm. 11, pp. 5016-5026

  16. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men

    European Journal of Endocrinology, Vol. 161, Núm. 6, pp. 947-954